Itaconix (ITX) Trading update summary

Financial performance

• Achieved record unaudited H1 2025 revenues of $4.8 million, up 73% year-on-year and 30% over H2 2024.

• Maintained gross profit margins, resulting in record half-year gross profits.

• Net cash and investments at June 30, 2025, stood at $5.7 million, reflecting inventory investments.

Segment and geographic growth

• Cleaning segment revenues rose 87% to $4.3 million, driven by scale inhibitors and SPARX™ program success.

• Hygiene and beauty revenues grew 9% to $0.5 million.

• European revenues surged 149% year-on-year, mainly from recurring orders.

• North America revenues increased 53%, supported by new and recurring detergent customers.

Strategic initiatives and product launches

• Launched BIO*Asterix®, targeting paints, coatings, and adhesives, establishing a third revenue stream.

• Extended and expanded global supply and marketing collaboration with Croda Inc. for odour control in homecare.

• Introduced a new ingredient for odour control in fabric cleaning, deepening technical cooperation.